Samsara Inc vs uniQure N.V. Ordinary Shares — how do they compare? Samsara Inc trades at $40.47 (market cap $23.89B), while uniQure N.V. Ordinary Shares trades at $20.71 (market cap $1.45B). The key difference: Samsara Inc is far larger — about 16.5× uniQure N.V. Ordinary Shares's market cap, and Samsara Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Samsara Inc for 19 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| IOT | QURE | |
|---|---|---|
Market Cap | $23.89B | $1.45B |
Volume | 4,063,536 | 3,323,243 |
Sector | Technology | Health |
52-Week High | $45.22 | $70.59 |
52-Week Low | $24.25 | $9.03 |
Typical Hold Time | 19 Days | 0 Days |
Enterprise Value | $23.13B | $707.46M |
Signals from Pluang's Aura AI — not financial advice
IOT (Samsara Inc.) trades at $41.27, down 0.84% on the day, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates with $0.20 actual versus $0.16 expected, and achieved 30% year-over-year revenue growth. Analyst consensus is strongly positive with a $51.15 price target. Recent news highlights partnerships and product launches, including the Samsara MCP for AI integration and a rewards program for drivers.
The outlook remains favorable due to robust revenue growth and expanding large-customer adoption, though high valuation multiples (P/E 272, P/S 12.88) pose risks. Key opportunities include AI-driven operational efficiencies and market expansion, while risks involve cash flow pressures and competitive threats. Institutional interest is strong, with the California State Teachers Retirement System increasing its stake significantly in Q2 2026.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →